Redefining response in wet AMD to anti VEGF therapy based on non-OCTA versus OCTA evaluation

Anti vascular endothelial growth factor (anti VEGF) has been the mainstay of treatment in wet age-related macular degeneration (AMD). Subsequent decision to continue anti VEGF therapy depends on the treatment response quantified by functional (visual acuity) and morphological (optical coherence tomography) parameters then categorized from good to poor.This study evaluates the agreement between OCT angiography (OCTA) and non-OCTA (logMAR VA plus...